Health Kick: Investors eye AdAlta’s fibrosis fighting i-body platform
Health & Biotech
Link copied to
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Tim Oldham, CEO and managing director of AdAlta Limited (ASX:1AD).
AdAlta is a clinical stage biotechnology company using its i-body platform to discover and develop next generation protein therapeutics addressing drug targets that are challenging for other technologies.
The company was recently featured in Stockhead’s 90 Seconds interview series.
So tune in below to hear the pair discuss all things AdAlta.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!